Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Zentalis Pharmaceuticals Inc’s current trading price is -81.41% away from its 52-week high, while its distance from the 52-week low is 26.32%. The stock’s price range over this period has fluctuated between $2.66 and $18.07. The company, operating within the financial sector, had a trading volume of approximately 1.18 million for the day, which was noticeably lower than the average daily share volume of 2.07 million over the last 3 months.
The market performance of Zentalis Pharmaceuticals Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $18.07 on 02/28/24, while the lowest value for the same duration was $2.66 on 10/31/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Zentalis Pharmaceuticals Inc (ZNTL) has experienced a quarterly rise of 3.38% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 239.45M and boasts a workforce of 168 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.46, with a change in price of -0.61. Similarly, Zentalis Pharmaceuticals Inc recorded 1,620,737 in trading volume during the last 100 days, posting a change of -15.37%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ZNTL stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.
ZNTL Stock Stochastic Average
Today, Zentalis Pharmaceuticals Inc’s raw stochastic average for the past 50 days stands at 39.33%, indicating a rise from the raw stochastic average of the last 20 days, which was 29.87%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 43.75% and 49.79% respectively.
ZNTL Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price decrease of -77.82%. However, over the past six months, we’ve seen a stronger performance of -70.63%. The price of ZNTL fallen by 1.20% over the last 30 days. And in the last five days, it has fallen by -4.00%.
